Blog
RSS FeedPosted by Michael Wonder on 24 Feb 2026
PHARMAC proposes to widen access to two medicines for people with melanoma
24 February 2026 - PHARMAC is proposing to widen access to two medicines used to treat melanoma, giving people another ...
Posted by Michael Wonder on 18 Feb 2026
PHARMAC proposes funding new treatments that could transform early care for people with chronic lymphocytic leukaemia, a type of blood cancer
18 February 2026 - People in New Zealand living with chronic lymphocytic leukaemia could soon benefit from funded access to ...
Posted by Michael Wonder on 05 Feb 2026
PHARMAC proposes wider access to a treatment for people with a rare blood cancer
4 February 2026 - People in New Zealand living with a rare type of blood cancer, systemic anaplastic large cell ...
Posted by Michael Wonder on 01 Feb 2026
New Zealand Pharmaceutical Schedule - 1 February 2026
1 February 2026 - The February 2026 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 27 May 2025
Schedule rule changes will improve continuity of cancer care
23 May 2025 - PHARMAC is proposing a change to the Pharmaceutical Schedule rules, which if agreed, would give New ...
Posted by Michael Wonder on 08 May 2025
PHARMAC funds and widens access to melanoma medicines
9 May 2025 - PHARMAC is funding more medicines for people with skin cancer (melanoma), from 1 June 2025. ...
Posted by Michael Wonder on 12 Mar 2025
PHARMAC to fund more cancer medicines (March 2025)
12 March 2025 - PHARMAC is funding six more medicines for cancers and one for antibiotic resistant infections. ...
Posted by Michael Wonder on 16 Jan 2025
PHARMAC consulting on widening access to venetoclax, azacitidine and upadacitinib monohydrate
16 January 2025 - PHARMAC is asking for feedback on a proposal to widen access to three medicines for five ...
Posted by Michael Wonder on 03 Jan 2025
New Zealand Pharmaceutical Schedule - 1 January 2025
1 January 2025 - The January 2025 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 22 Dec 2024
PHARMAC consulting on six medicines for New Zealanders
19 December 2024 - PHARMAC is asking for feedback on proposals to fund six medicines for cancer and antibiotic resistant ...
Posted by Michael Wonder on 05 Dec 2024
PHARMAC funds more cancer and respiratory medicines for New Zealanders
6 December 2024 - More publicly funded medicines are on the way for people with types of breast and lung ...
Posted by Michael Wonder on 03 Dec 2024
New Zealand Pharmaceutical Schedule - 1 December 2024
1 December 2024 - The December 2024 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 08 Nov 2024
Newly funded medicine to benefit 110 more people with thyroid, liver, and kidney cancer
8 November 2024 - PHARMAC has decided to fund lenvatinib from 1 December 2024 for people with some types of ...
Posted by Michael Wonder on 07 Nov 2024
PHARMAC publishes agenda for the November 2024 PTAC meeting
6 November 2024 - PHARMAC has published the agenda for the upcoming 14-15 November 2024 PTAC meeting. ...
Posted by Michael Wonder on 01 Nov 2024
New Zealand Pharmaceutical Schedule - 1 November 2024
1 November 2024 - The November 2024 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...